Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Nitric Oxide for MRSA Positive Ulcers
NCT00790608Phase 2Terminated
- Sponsor
- Nitric BioTherapeutics
- Start
- Jan 2009
- Primary completion
- May 2009
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of nitric oxide in Staphylococcus aureus infection, skin ulcer, sponsored by Nitric BioTherapeutics. Started Jan 2009; status: terminated.
02
Drugs
nitric oxide
03
Conditions
Staphylococcus aureus infectionskin ulcer
Beyond the preview
Go deeper on NCT00790608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790608.